Blog

Home  /  EUnetHTA Joint Action 3 (2016-2021)   /  OTCA23 Final Assessment Report “Biodegradable rectum spacers to reduce toxicity for prostate cancer” now available

OTCA23 Final Assessment Report “Biodegradable rectum spacers to reduce toxicity for prostate cancer” now available

The Other Technologies Collaborative Assessment OTCA23 final assessment report “Biodegradable rectum spacers to reduce toxicity for prostate cancer”, together with related documentation, is now available for access.

The assessed technology is biodegradable rectum spacers added to conventional radiotherapy to (temporarily) position the prostate away from the rectum with the aim of reducing the side effects of radiotherapy. The objective of this rapid relative effectiveness assessment was to collaboratively address the research question: Is the application of a biodegradable rectum spacer more effective and/or safer for rectum toxicity than no rectum spacer for adult oncological patients with prostate cancer receiving curative radiotherapy?

The final assessment report and related documents are available here:

OTCA23 – Final Assessment Report

OTCA23 – Fact check comments from manufacturers including author replies

OTCA23 – Comments from external experts

Please access the project plan and related documents at the following links:

OTCA23 Final Project Plan

Fact check comments from manufacturers including author replies

Comments from the external experts